OS-2966 is a humanised de-immunised monoclonal antibody that targets and inhibits the adhesion receptor subunit Integrin b1/ITGB1/CD29, and can be used for the treatment of malignant gliomas, glioblastomas, and astrocytomas.
Purity:
0.9935
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted
